Kevin Cure, | |
31121 County Road X, Stratton, CO 80836-8705 | |
(651) 485-9040 | |
Not Available |
Full Name | Kevin Cure |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 31121 County Road X, Stratton, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851720635 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 0001213 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kevin Cure, 31121 County Road X, Stratton, CO 80836-8705 Ph: (651) 485-9040 | Kevin Cure, 31121 County Road X, Stratton, CO 80836-8705 Ph: (651) 485-9040 |
News Archive
Even if you are not a cook, you might have wondered why a pinch of flour (or any small particles) thrown into a bowl of water will disperse in a dramatic fashion, radiating outward as if it was exploding. Pushpendra Singh, PhD, a mechanical engineering professor at NJIT who has studied and written about the phenomenon, has not only thought about it, but can explain why.
Applying bioinformatics to resolve biological problems. This is the objective of the research group of the University of Malaga "BI4NEXT", which, in one of its latest studies, developed in the Supercomputing and Bioinnovation Center based on biobank samples, has identified new biomarkers for the diagnosis, prognosis and even treatment of lung cancer.
Kaiser Health News details how many Olympic athletes get health insurance, while the Associated Press reports on a new wellness program for NFL players.
Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the acquisition of the world's largest cryo-preserved human cancer tissue bankāmore than 144,000 specimens procured over 20 years. The company acquired the tumor bank, along with properly de-identified clinical information and validated test procedures, as part of a major acquisition of key assets formerly owned by Oncotech.
› Verified 4 days ago